Evidence map›Paper›PMID 32825187›Full record

ArticleInternational journal of molecular sciences2020

The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner.

Anke Seifert, Justyna Wozniak, Stefan Düsterhöft, Petr Kasparek, Radislav Sedlacek, Stephan Dreschers, Thorsten W Orlikowsky, Daniela Yildiz, Andreas Ludwig

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Cells · 2022
    Article
  6. International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anke SeifertInstitute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Justyna WozniakInstitute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Stefan DüsterhöftInstitute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Petr KasparekCzech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic.ORCID 0000-0001-6047-7538
Radislav SedlacekCzech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic.
Stephan DreschersDepartment of Neonatology, University Children's Hospital, 52074 Aachen, Germany.
Thorsten W OrlikowskyDepartment of Neonatology, University Children's Hospital, 52074 Aachen, Germany.
Daniela YildizInstitute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Andreas LudwigInstitute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
RWTH Aachen University · DECzech Academy of Sciences, Institute of Molecular Genetics · CZUniversitätsklinikum Aachen · DE

Funding

Deutsche Forschungsgemeinschaft Dr1013/1-1Deutsche Forschungsgemeinschaft Lu869/8-1European Regional Development Fund OP RDI CZ.1.05/2.1.00/19.0395Ministry of Education, Youth and Science OP RDI CZ.1.05/2.1.00/19.0395
6 · The paper itself

Abstract

Uptake of bacteria by phagocytes is a crucial step in innate immune defence. Members of the disintegrin and metalloproteinase (ADAM) family critically control the immune response by limited proteolysis of surface expressed mediator molecules. Here, we investigated the significance of ADAM17 and its regulatory adapter molecule iRhom2 for bacterial uptake by phagocytes. Inhibition of metalloproteinase activity led to increased phagocytosis of pHrodo labelled Gram-negative and -positive bacteria (

Indexed as

ADAM17 ProteinAnimalsCD36 AntigensCells, CulturedEscherichia coliHumansInterleukin-8Intracellular Signaling Peptides and ProteinsMicePhagocytesPhagocytosisRAW 264.7 CellsReceptors, Tumor Necrosis Factor, Type IStaphylococcus aureusTHP-1 CellsToll-Like Receptor 6ADAM17 ProteinADAM17 protein, humanCD36 AntigensCD36 protein, humanInterleukin-8Intracellular Signaling Peptides and ProteinsReceptors, Tumor Necrosis Factor, Type IRHBDF2 protein, humanTLR6 protein, humanToll-Like Receptor 6ADAM17bacterial phagocytosischemokinesinfectioninflammationiRhom2metalloproteinasephagocytesshedding

Identifiers

PMID32825187
PMCPMC7503280
OpenAlexW3075596631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.